The effect of granulocyte-macrophage colony-stimulating factor on myeloid cells and its clinical applications - PubMed
Review
The effect of granulocyte-macrophage colony-stimulating factor on myeloid cells and its clinical applications
A D Hill et al. J Leukoc Biol. 1995 Dec.
Abstract
Granulocyte-macrophage colony-stimulating factor (GM-CSF) is a naturally occurring growth factor produced by several cell types in response to a variety of stimuli. GM-CSF has potent stimulatory effects on the growth and maturation of hematopoietic cells and has profound effects on mature circulating effector cells. Clinical applications of GM-CSF include ameliorating chemotherapy-induced neutropenia and enhancing hematopoietic recovery after bone marrow transplantation. This review evaluates the effect of GM-CSF on myeloid cells and its clinical applications.
Similar articles
-
Clinical applications of human granulocyte-macrophage colony-stimulating factor.
Sakamoto KM, Gasson JC. Sakamoto KM, et al. Int J Cell Cloning. 1991 Nov;9(6):531-41. doi: 10.1002/stem.5530090603. Int J Cell Cloning. 1991. PMID: 1770227 Review.
-
Southwestern Internal Medicine Conference: clinical use of hematopoietic growth factors.
Fleischman RA. Fleischman RA. Am J Med Sci. 1993 Apr;305(4):248-73. doi: 10.1097/00000441-199304000-00009. Am J Med Sci. 1993. PMID: 7682752 Review.
-
Granulocyte-macrophage colony-stimulating factor (GM-CSF): preclinical and clinical investigations.
Demetri GD, Antman KH. Demetri GD, et al. Semin Oncol. 1992 Aug;19(4):362-85. Semin Oncol. 1992. PMID: 1509275 Review.
-
Ulich TR, del Castillo J, McNiece I, Watson L, Yin SM, Andresen J. Ulich TR, et al. Am J Pathol. 1990 Aug;137(2):369-76. Am J Pathol. 1990. PMID: 1696784 Free PMC article.
-
Hematopoietic management in oncology practice. Part 1. Myeloid growth factors.
Glaspy JA. Glaspy JA. Oncology (Williston Park). 2003 Nov;17(11):1593-603. Oncology (Williston Park). 2003. PMID: 14682110 Review.
Cited by
-
GM-CSF: An immune modulatory cytokine that can suppress autoimmunity.
Bhattacharya P, Thiruppathi M, Elshabrawy HA, Alharshawi K, Kumar P, Prabhakar BS. Bhattacharya P, et al. Cytokine. 2015 Oct;75(2):261-71. doi: 10.1016/j.cyto.2015.05.030. Epub 2015 Jun 22. Cytokine. 2015. PMID: 26113402 Free PMC article. Review.
-
Dohlman TH, Ding J, Dana R, Chauhan SK. Dohlman TH, et al. Invest Ophthalmol Vis Sci. 2017 Feb 1;58(2):1330-1336. doi: 10.1167/iovs.16-20789. Invest Ophthalmol Vis Sci. 2017. PMID: 28241321 Free PMC article.
-
Nierhaus A, Montag B, Timmler N, Frings DP, Gutensohn K, Jung R, Schneider CG, Pothmann W, Brassel AK, Schulte Am Esch J. Nierhaus A, et al. Intensive Care Med. 2003 Apr;29(4):646-51. doi: 10.1007/s00134-003-1666-6. Epub 2003 Feb 21. Intensive Care Med. 2003. PMID: 12595977
-
Maxwell AJ, Ding J, You Y, Dong Z, Chehade H, Alvero A, Mor Y, Draghici S, Mor G. Maxwell AJ, et al. J Leukoc Biol. 2021 Jan;109(1):35-47. doi: 10.1002/JLB.4COVR0920-552RR. Epub 2020 Nov 26. J Leukoc Biol. 2021. PMID: 33242368 Free PMC article. Review.
-
Subramanian G, Chaudhury P, Malu K, Fowler S, Manmode R, Gotur D, Zwerger M, Ryan D, Roberti R, Gaines P. Subramanian G, et al. J Immunol. 2012 Jan 1;188(1):85-102. doi: 10.4049/jimmunol.1003804. Epub 2011 Dec 2. J Immunol. 2012. PMID: 22140257 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources